TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank83
3Y CAGR+99.7%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
+99.7%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
8x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025266.65%
2024-86.62%
202355.52%
202233.47%
2021834.65%
20200.00%
20190.00%